ClinVar Miner

Submissions for variant NG_009091.1(KCNE1):g.[66853A>C;66857T>C]

dbSNP: rs281865421
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001244610 SCV001417840 likely pathogenic Long QT syndrome 2024-10-30 criteria provided, single submitter clinical testing This variant, c.172_177delinsCCCCCT, is a complex sequence change that results in the deletion of 2 and insertion of 2 amino acid(s) in the KCNE1 protein (p.Thr58_Leu59delinsProPro). Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This variant has been observed in individuals with Jervell and Lange-Nielsen syndrome and/or long QT syndrome (PMID: 9328483, 10973849, 31941373; internal data). It has also been observed to segregate with disease in related individuals. This variant is also known as T59P/L60P. ClinVar contains an entry for this variant (Variation ID: 132658). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt KCNE1 protein function with a positive predictive value of 95%. Experimental studies have shown that this variant affects KCNE1 function (PMID: 11530100, 19907016). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
GeneDx RCV001588813 SCV001822422 likely pathogenic not provided 2024-06-06 criteria provided, single submitter clinical testing Not observed in large population cohorts (gnomAD); Published functional studies demonstrate that the p.(T58P)/p.(L59P) variant severely weakens the interaction of KCNE1 with KCNQ1 and leads to an inability to modulate channel gating and the production of currents that lack the slow activation profile (PMID: 19907016); In silico analysis supports a deleterious effect on protein structure/function; Also known as p.(T59P)/p.(L60P) or p.(T58P)/p.(L59P) (PMID: 9328483, 11530100, 19907016); This variant is associated with the following publications: (PMID: 11530100, 11692163, 26410412, 9328483, 31941373, 19907016, 10973849)
Fulgent Genetics, Fulgent Genetics RCV002476967 SCV002787877 likely pathogenic Jervell and Lange-Nielsen syndrome 2; Long QT syndrome 5 2021-10-21 criteria provided, single submitter clinical testing
OMIM RCV000014417 SCV000034666 pathogenic Jervell and Lange-Nielsen syndrome 2 1997-11-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.